X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4973) 4973
Book Review (727) 727
Publication (205) 205
Newsletter (75) 75
Newspaper Article (33) 33
Magazine Article (14) 14
Conference Proceeding (13) 13
Book Chapter (10) 10
Dissertation (3) 3
Web Resource (3) 3
Book / eBook (2) 2
Data Set (2) 2
Transcript (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4020) 4020
humans (3630) 3630
ciprofloxacin (3080) 3080
male (2115) 2115
female (1920) 1920
adult (1439) 1439
middle aged (1344) 1344
ciprofloxacin - therapeutic use (1238) 1238
aged (1150) 1150
ciprofloxacin - adverse effects (1087) 1087
pharmacology & pharmacy (1062) 1062
antibiotics (1014) 1014
fluoroquinolones (802) 802
ciprofloxacin - administration & dosage (764) 764
anti-bacterial agents - therapeutic use (735) 735
infectious diseases (721) 721
microbiology (663) 663
anti-infective agents - adverse effects (640) 640
anti-infective agents - therapeutic use (612) 612
animals (600) 600
treatment outcome (583) 583
adolescent (564) 564
abridged index medicus (518) 518
anti-bacterial agents - administration & dosage (485) 485
anti-bacterial agents - adverse effects (459) 459
administration, oral (453) 453
aged, 80 and over (452) 452
microbial sensitivity tests (447) 447
levofloxacin (437) 437
medicine, general & internal (431) 431
infections (395) 395
ciprofloxacin - pharmacology (378) 378
health aspects (374) 374
quinolones (373) 373
analysis (372) 372
anti-infective agents - administration & dosage (372) 372
pharmacokinetics (372) 372
risk factors (368) 368
child (361) 361
anti-bacterial agents - pharmacology (355) 355
prospective studies (349) 349
drug therapy (339) 339
therapy (335) 335
drug therapy, combination (315) 315
ofloxacin (303) 303
bacterial infections - drug therapy (288) 288
bacteria (283) 283
infection (282) 282
double-blind method (261) 261
drug interactions (257) 257
immunology (253) 253
medicine & public health (252) 252
research (252) 252
urinary tract infections - drug therapy (243) 243
child, preschool (234) 234
ciprofloxacin - pharmacokinetics (233) 233
surgery (231) 231
retrospective studies (227) 227
resistance (224) 224
drugs (223) 223
care and treatment (218) 218
anti-infective agents - pharmacokinetics (214) 214
urology & nephrology (210) 210
anti-infective agents - pharmacology (207) 207
oncology (203) 203
drug administration schedule (201) 201
norfloxacin (197) 197
dosage and administration (194) 194
drug resistance (194) 194
drug resistance, bacterial (194) 194
time factors (194) 194
safety (192) 192
dose-response relationship, drug (189) 189
antimicrobial agents (188) 188
internal medicine (184) 184
children (183) 183
escherichia-coli (182) 182
complications and side effects (180) 180
fluoroquinolone (177) 177
toxicology (175) 175
double-blind (174) 174
infant (174) 174
antibacterial agents (172) 172
pediatrics (172) 172
toxicity (170) 170
young adult (170) 170
acute disease (168) 168
efficacy (166) 166
pseudomonas infections - drug therapy (166) 166
urinary tract infections (165) 165
fluoroquinolones - adverse effects (164) 164
drug resistance in microorganisms (163) 163
environmental sciences (163) 163
follow-up studies (162) 162
drug resistance, microbial (161) 161
in-vitro (158) 158
antibiotic prophylaxis (157) 157
ofloxacin - adverse effects (155) 155
management (152) 152
moxifloxacin (150) 150
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4860) 4860
Spanish (65) 65
French (51) 51
German (44) 44
Russian (23) 23
Japanese (12) 12
Italian (11) 11
Dutch (6) 6
Swedish (6) 6
Danish (5) 5
Polish (5) 5
Chinese (4) 4
Bulgarian (3) 3
Hebrew (3) 3
Portuguese (3) 3
Romanian (3) 3
Turkish (3) 3
Croatian (2) 2
Norwegian (2) 2
Czech (1) 1
Hungarian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


12/2009
Ciprofloxacin is one of the most commonly used antibacterial agents with relatively few side effects. Serious adverse reactions reported with ciprofloxacin are... 
agranulocytosis | Adverse drug effects | toxic epidermal necrolysis | ciprofloxacin
Web Resource
Cancer, ISSN 0008-543X, 07/2014, Volume 120, Issue 13, pp. 1985 - 1992
Outpatient intravenous antibiotic prophylaxis reduces the incidence of clinically or microbiologically documented infection and bacteremia, especially viridans... 
infection | acute myeloid leukemia | children | antibiotics | prophylaxis | MORTALITY | PEDIATRIC ONCOLOGY PATIENTS | CANCER | CHEMOTHERAPY | TRIAL | INTENSIVE TREATMENT | THERAPY | ONCOLOGY | BACTERIAL-INFECTION | MINIMAL RESIDUAL DISEASE | EPIDEMIOLOGY | Humans | Chemotherapy-Induced Febrile Neutropenia - prevention & control | Child, Preschool | Infant | Male | Antibiotic Prophylaxis - adverse effects | Candidiasis - diagnosis | Feasibility Studies | Incidence | Outpatients - statistics & numerical data | Bacteremia - microbiology | Young Adult | Anti-Bacterial Agents - therapeutic use | Bacteremia - prevention & control | Leukemia, Myeloid, Acute - drug therapy | Female | Anti-Bacterial Agents - adverse effects | Retrospective Studies | Drug Therapy, Combination | Child | Antibiotic Prophylaxis - utilization | Bacterial Infections - microbiology | Rectum - microbiology | Vancomycin - administration & dosage | Administration, Oral | Leukemia, Myeloid, Acute - pathology | Antibiotic Prophylaxis - methods | Treatment Outcome | Cephalosporins - administration & dosage | Induction Chemotherapy - adverse effects | Bacterial Infections - prevention & control | Ciprofloxacin - administration & dosage | Adolescent | Bacterial Infections - epidemiology | Antibiotic Prophylaxis - trends | Infusions, Intravenous | Nose - microbiology | Consolidation Chemotherapy - adverse effects | Neoplasm Staging | Anti-Bacterial Agents - administration & dosage | Antibacterial agents | Usage | Patient outcomes | Index Medicus | Abridged Index Medicus
Journal Article
02/2009
Background: Ciprofloxacin is a commonly prescribed antibiotic in the treatment of genitourinary tract infection. Objective: The aim of this study was to... 
Testis | Rat | Sperm | Ciprofloxacin | Apoptosis
Web Resource
Reproductive Toxicology, ISSN 0890-6238, 01/2018, Volume 75, pp. 86 - 95
Here we report a retrospective analysis of negative effects of routine enrofloxacin treatment of recurrent diarrhea on the ovary and the developing oocytes of... 
Embryo | Marmoset monkey | Fluoroquinolone | Reproductive toxicity | Enrofloxacin | Oocyte | TOPOISOMERASE-II | FERTILIZATION | CHONDROCYTES | ABNORMALITIES | PROLIFERATION | CALLITHRIX-JACCHUS | CYTOSKELETAL | NORFLOXACIN | REPRODUCTIVE BIOLOGY | VITRO MATURATION | TOXICOLOGY | CIPROFLOXACIN | Primates | Diarrhea | Complications and side effects | Antibacterial agents | Analysis | Index Medicus
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2013, Volume 13, Issue 1, pp. 27 - 35
Summary Background Intensified antibiotic treatment might improve the outcome of tuberculous meningitis. We assessed pharmacokinetics, safety, and survival... 
Infectious Disease | MYCOBACTERIUM-TUBERCULOSIS | ETHAMBUTOL | INFECTIOUS DISEASES | IN-VITRO | PHARMACOKINETICS | LEVOFLOXACIN | PULMONARY TUBERCULOSIS | INFECTION | DRUG-RESISTANCE | CEREBROSPINAL-FLUID | CIPROFLOXACIN | Fluoroquinolones | Aza Compounds - pharmacokinetics | Antitubercular Agents - adverse effects | Rifampin - pharmacokinetics | Antibiotics, Antitubercular - adverse effects | Follow-Up Studies | Humans | Middle Aged | Aza Compounds - adverse effects | Male | Quinolines - administration & dosage | Quinolines - pharmacokinetics | Young Adult | Drug Therapy, Combination - adverse effects | Rifampin - adverse effects | Adult | Female | Rifampin - administration & dosage | Antibiotics, Antitubercular - administration & dosage | Aza Compounds - administration & dosage | Anti-Infective Agents - adverse effects | Antibiotics, Antitubercular - pharmacokinetics | Tuberculosis, Meningeal - drug therapy | Drug Administration Schedule | Drug Therapy, Combination - methods | Anti-Infective Agents - administration & dosage | Antitubercular Agents - pharmacokinetics | Anti-Infective Agents - pharmacokinetics | Adolescent | Antitubercular Agents - administration & dosage | Tuberculosis, Meningeal - metabolism | Quinolines - adverse effects | Indonesia | Tuberculosis | Meningitis | Dosage and administration | Product development | Moxifloxacin | Universities and colleges | Rifampin | Index Medicus
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 11/2009, Volume 180, Issue 9, pp. 896 - 902
Rationale: The optimal therapeutic regimen and duration of treatment for Mycobacterium abscessus lung disease is not well established. Objectives: To assess... 
Treatment outcome | Lung diseases | Mycobacterium abscessus | Atypical mycobacteria | lung diseases | DIAGNOSIS | INFECTIONS | NONTUBERCULOUS MYCOBACTERIA | CLARITHROMYCIN RESISTANCE | treatment outcome | CHELONAE | atypical mycobacteria | RAPIDLY GROWING MYCOBACTERIA | IN-VITRO | RESPIRATORY SYSTEM | MULTIDRUG-RESISTANT TUBERCULOSIS | SP-NOV | NODULAR BRONCHIECTASIS | CRITICAL CARE MEDICINE | Sputum - microbiology | Lung - microbiology | Cefoxitin - therapeutic use | Lung Diseases - microbiology | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Lung - diagnostic imaging | Lung Diseases - drug therapy | Anti-Bacterial Agents - therapeutic use | Sputum - drug effects | Liver - drug effects | Mycobacterium Infections, Nontuberculous - microbiology | Adult | Female | Anti-Bacterial Agents - adverse effects | Retrospective Studies | Drug Therapy, Combination | Neutropenia - chemically induced | Chemical and Drug Induced Liver Injury - etiology | Doxycycline - adverse effects | Ciprofloxacin - adverse effects | Nontuberculous Mycobacteria - drug effects | Clarithromycin - adverse effects | Doxycycline - therapeutic use | Ciprofloxacin - therapeutic use | Anti-Infective Agents - therapeutic use | Treatment Outcome | Clarithromycin - therapeutic use | Thrombocytopenia - chemically induced | Nontuberculous Mycobacteria - isolation & purification | Amikacin - adverse effects | Amikacin - therapeutic use | Lung - drug effects | Cefoxitin - adverse effects | Mycobacterium Infections, Nontuberculous - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
JAMA Internal Medicine, ISSN 2168-6106, 10/2014, Volume 174, Issue 10, pp. 1605 - 1612
Journal Article
Journal Article
European Journal of Pharmaceutics and Biopharmaceutics, ISSN 0939-6411, 10/2015, Volume 96, pp. 314 - 321
Journal Article
British Journal of Haematology, ISSN 0007-1048, 09/2011, Volume 154, Issue 5, pp. 644 - 653
Drug‐induced immune haemolytic anaemia is a rare but serious condition. This study investigated the possibility of drug aetiology of immune haemolytic anaemia... 
immune haemolytic anaemia | drug‐induced | Berlin case‐control surveillance study | causality assessment | case‐control study | Case-control study | Causality assessment | Berlin case-control surveillance study | Immune haemolytic anaemia | Drug-induced | AUTOANTIBODIES | CEFTRIAXONE | OXALIPLATIN | FLUDARABINE | case-control study | CHRONIC LYMPHOCYTIC-LEUKEMIA | THROMBOCYTOPENIA | drug-induced | DEPENDENT ANTIBODIES | OF-THE-LITERATURE | HEMATOLOGY | CIPROFLOXACIN | Humans | Middle Aged | Male | Case-Control Studies | Young Adult | Lorazepam - adverse effects | Antineoplastic Agents - adverse effects | Drug-Related Side Effects and Adverse Reactions | Aged, 80 and over | Adult | Female | Anti-Bacterial Agents - adverse effects | Odds Ratio | Ciprofloxacin - adverse effects | Diclofenac - adverse effects | Berlin | Vidarabine - adverse effects | Anemia, Hemolytic, Autoimmune - chemically induced | Trimethoprim, Sulfamethoxazole Drug Combination - adverse effects | Vidarabine - analogs & derivatives | Piperacillin - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anemia, Hemolytic, Autoimmune - epidemiology | Adolescent | beta-Lactams - adverse effects | Aged | Population Surveillance | Drugs | Medical colleges | Lorazepam | Beta lactamases | Immunogenetics | Ciprofloxacin | Index Medicus | Anemia | Ceftriaxone | Immunosuppressive agents | Risk factors | Diclofenac | Antibiotics | Piperacillin | fludarabine | oxaliplatin | cotrimoxazole
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9981, pp. 1949 - 1956
Journal Article